GLP-1RAs, specifically liraglutide, have also been evaluated for their effects on cardiovascular biomarkers
FMT is also being explored: an open-label trial of FMT in MS demonstrated safety and hinted at some improvements in gut microbiome diversity and fatigue scores, and a placebo-controlled Phase I FMT trial in progressive MS is currently underway to assess impacts on MRI lesions and clinical outcomes [203, 204]
Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults
It is typically administered in the upper arm
The experiment was divided into sham surgery group, I/R model group, and I/R+IGF-1 LR3 treatment group (0.5mg/kg, orally administered 30 minutes before reperfusion)
E.CantatoreP.et al (2016)